88 related articles for article (PubMed ID: 17413686)
1. Therapeutic management of bone demineralization in the HIV-infected population.
Negredo E; Martínez E; Cinquegrana D; Estany C; Clotet B
AIDS; 2007 Mar; 21(6):657-63. PubMed ID: 17413686
[No Abstract] [Full Text] [Related]
2. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroids: no drug prevention of fractures needed.
Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
[TBL] [Abstract][Full Text] [Related]
4. Management of bone mineral density in HIV-infected patients.
Negredo E; Bonjoch A; Clotet B
Expert Opin Pharmacother; 2016; 17(6):845-52. PubMed ID: 26809940
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of bisphosphonates in the treatment of HIV-related bone pain in perinatally infected pediatric patients.
Fortuny C; Noguera A; Alsina L; Villaronga M; Vidal-Sicart S; Sánchez E
AIDS; 2008 Sep; 22(14):1888-90. PubMed ID: 18753870
[No Abstract] [Full Text] [Related]
6. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
[TBL] [Abstract][Full Text] [Related]
8. [Anorexia nervosa and its consequences on bone: a therapeutic challenge].
Trombetti A; Richert L; Rizzoli R
Rev Med Suisse; 2007 Jun; 3(115):1502-5. PubMed ID: 17682792
[TBL] [Abstract][Full Text] [Related]
9. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.
Hagino H; Nishizawa Y; Sone T; Morii H; Taketani Y; Nakamura T; Itabashi A; Mizunuma H; Ohashi Y; Shiraki M; Minamide T; Matsumoto T
Bone; 2009 Jun; 44(6):1078-84. PubMed ID: 19264155
[TBL] [Abstract][Full Text] [Related]
10. Dental enamel dissolution after alendronate treatment.
Gandolfi MG; Nucci C; Prati C; Mongiorgi R
Am J Dent; 2007 Aug; 20(4):235-40. PubMed ID: 17907486
[TBL] [Abstract][Full Text] [Related]
11. Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy.
Swenson KK; Nissen MJ; Anderson E; Shapiro A; Schousboe J; Leach J
J Support Oncol; 2009; 7(3):101-7. PubMed ID: 19507458
[TBL] [Abstract][Full Text] [Related]
12. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
[TBL] [Abstract][Full Text] [Related]
13. Calcium supplements in patients with prostate cancer.
Molokwu CN
BJU Int; 2007 Dec; 100(6):1411. PubMed ID: 17979937
[No Abstract] [Full Text] [Related]
14. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
[No Abstract] [Full Text] [Related]
15. [Alendronate].
Okazaki R
Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
[TBL] [Abstract][Full Text] [Related]
16. Underdiagnosis and under-treatment of osteoporosis following fragility fracture.
Aboyoussef M; Vierkoetter KR
Hawaii Med J; 2007 Jul; 66(7):185-7. PubMed ID: 17879856
[TBL] [Abstract][Full Text] [Related]
17. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
[TBL] [Abstract][Full Text] [Related]
18. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons.
Clay PG; Voss LE; Williams C; Daume EC
Ann Pharmacother; 2008 May; 42(5):670-9. PubMed ID: 18413693
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of osteoporosis in an active female patient?].
Fassbender WJ
Dtsch Med Wochenschr; 2008 Nov; 133(46):2416. PubMed ID: 18988136
[No Abstract] [Full Text] [Related]
20. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
